Circulating Levels of PD-L1 in Mesothelioma Patients from the NIBIT-MESO-1 Study: Correlation with Survival

Targeting of the programmed cell death protein (PD)-1/programmed death-ligand 1 (PD-L1) axis has shown a significant clinical impact in several tumor types. Accordingly, our phase II NIBIT-MESO-1 study demonstrated an improved clinical efficacy in mesothelioma patients treated with the anti-PD-L1 du...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cancers (Basel)
Glavni autori: Chiarucci, Carla, Cannito, Sara, Daffinà, Maria Grazia, Amato, Giovanni, Giacobini, Gianluca, Cutaia, Ornella, Lofiego, Maria Fortunata, Fazio, Carolina, Giannarelli, Diana, Danielli, Riccardo, Di Giacomo, Anna Maria, Coral, Sandra, Calabrò, Luana, Maio, Michele, Covre, Alessia
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2020
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7072596/
https://ncbi.nlm.nih.gov/pubmed/32033266
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12020361
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items